News: Research
Cancer Drug with Better Staying Power and Reduced Toxicity Shows Preclinical Promise
The texaphyrin molecule is designed to be more easily absorbed by cancerous cells than healthy human cells, reducing the drug’s side effects.
The Texas Scientist
20/20 Foresight
So what will the next 50 years bring? Absent a crystal ball, your best bet would be to ask a scientist.
Kami Hull Seeks to Make Drugs Faster with Less Waste
Learn about Kami Hull's work as an organic chemist and how she won a prestigious Novartis Early Career Award in Chemistry.
5 Tips to Get the Most Out of Four Years of Undergrad Research
We asked graduating seniors from across the college to share their best tips for research success.
New Drug Has Potential to Protect Brain Cells from Traumatic Injuries
Stephen Martin and James Sahn have demonstrated that a new compound protects brain cells in mice that have been subjected to brain trauma, raising the prospects of a possible treatment for humans who experience TBI.